Pebble Labs Builds Management Team With New Hires



LOS ALAMOS, N.M., July 10, 2018 /PRNewswire/ -- Pebble Labs Inc. -- the biotechnology company developing solutions to safely and sustainably eliminate pathogens in aquaculture, agriculture, and vector-borne diseases without the use of herbicides, pesticides or antibiotics -- today announced the appointment of three medical industry executives to its management team.

"Pebble Labs is following the same strategy with our management team hiring that guides our science team build-out - attract and hire only the best, most experienced, highest achieving individuals from throughout the industry and around the world," said Michael Harrison, Chief Executive Officer and Chairman of the Board.

The new appointees are:

  • Dr. Rick DeRose, Director of Product Innovation -- Dr. DeRose has more than 25 years of experience in Ag Biotechnology at Syngenta and Bayer developing innovation strategies for R&D projects. He was co-inventor of the first commercialized Roundup Ready Corn varieties. Dr. DeRose received the ASPB 2017 Innovation Prize for Agricultural Technology for successfully translating discovery research into demonstrable, real-world outcomes on Global Agriculture, and is an Industry Fellow for the Center for Innovation Management Studies at North Carolina State University. He received a Ph.D. in Medical Microbiology and Immunology from Wake Forest School of Medicine. Dr. DeRose reports to Jon Bloodworth, Chief Operating Officer at Pebble Labs.
  • Dr. Anne Lo, Director of Strategic Development -- Dr. Lo trained as a veterinary surgeon and worked in a number of clinical positions. She subsequently joined management consulting firm Bain & Co in London, before moving to a strategy role with WorldPay. Dr. Lo was most recently with Horizons Ventures based in Hong Kong, where she primarily covered science and healthcare investments. Dr. Lo received her BSc and BVM&S degrees from the University of Edinburgh and Ph.D. from the University of Cambridge. Dr. Lo reports to Mr. Harrison.
  • Dr. Tichafa "Tich" Munyikwa, Director of Regulatory Affairs -- Dr. Munyikwa has more than 20 years' experience working in major Ag Biotechnology companies in positions as Senior Research Scientist and Global Regulatory Expert. He is an inventor with granted worldwide scientific patents and a track record of international product development and registration. His expertise lies in regulatory policy development and advocacy as well as business strategy and implementation. Fields covered include: Agribusiness, Biotechnology, Plant Molecular and Cell Biology, Biologicals, RNA interference, Genome Editing, and Synthetic Biology. Dr. Munyikwa received his Ph.D. in Cell and Molecular Biology from Wageningen University (The Netherlands). Dr. Munyikwa reports to Mr. Bloodworth.

The Pebble Labs management team is based in Santa Fe and at the New Mexico Consortium at the Los Alamos National Laboratory.

About Pebble Labs

Pebble Labs Inc. is a biotechnology company developing solutions to safely and sustainably eliminate pathogens in aquaculture, agriculture, and vector-borne diseases without the use of herbicides, pesticides or antibiotics.

The approach is a scientific breakthrough leveraging technology and biology developed over the last 10 years at top labs and universities. The solution naturally hinders an organism's ability to replicate targeted viruses via proprietary and patent-pending food-source bacteria designed to block virus replication. This is completely safe for all other organisms--including the targeted organism. The bacteria can be applied cost-effectively in affected areas across the globe.

Pebble Labs uses an innovative "distributed" model for scientific research, collaborating with world class experts in academia and the private sector and retains control over operations and ownership for all core IP. The company coordinates research from one central location (The New Mexico Consortium) and uses world-class facilities at Colorado State University, New Mexico State University, the National Center for Genome Resources, and others for research. This research is supplemented with oversight from a Scientific Advisory Board.

Pebble Labs' divisions apply its technology to aquaculture (Mermaid Bio), agriculture (IronLeaf), and mosquito and vector-borne diseases (LittleFly).

Thomas Walek
Peaks Strategies

View original content:

SOURCE Pebble Labs Inc.


Back to news